Skip to main content
OpenTrials

Clinical trial condition

Idiopathic Pulmonary Fibrosis

Explore clinical trials studying Idiopathic Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

330 public trials 43 recruiting studies
Refine in advanced search Browse all conditions

Idiopathic Pulmonary Fibrosis trial results

Completed

A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis

NCT02688647

Conditions
Fibrosis, Idiopathic Interstitial Pneumonias, Idiopathic Pulmonary Fibrosis, +6 more
Locations
  • Pulmonary Associates, PA Phoenix, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • UC Davis Medical Center, Division of Pulmonary/CC/SM Sacramento, California, United States
  • St. Francis Medical Institute Clearwater, Florida, United States
View Trial Details
Completed

Investigating Significant Health Trends in Idiopathic Pulmonary Fibrosis

NCT01695408

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Institute for Clinical Pharmacology, Medical Faculty, Technical University Dresden, Germany
  • Klinik für Pneumologie, Medizinische Hochschule Hannover Hanover, Germany
  • Pneumologie und Beatmungsmedizin, Thoraxklinik,Universitätsklinikum Heidelberg, Germany
  • Abteilung für Pneumologie Department Innere Medizin, Neurologie und Dermatologie Universitätsklinikum Leipzig AöR Leipzig, Germany
View Trial Details
Completed

Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough

NCT04318704

Conditions
Cough, Idiopathic Pulmonary Fibrosis, Lung Diseases, +7 more
Locations
  • Vale Medical Practice Brookvale, New South Wales, Australia
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • Cairns Hospital Cairns, Queensland, Australia
View Trial Details
Completed

A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

NCT02550873

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • UCSF Interstitial Lung Disease Program San Francisco, California, United States
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
View all 18 locations
View Trial Details

Related conditions